The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating tumor cell (CTC) enumeration in patients with metastatic neuroendocrine prostate cancer (NEPC) and castration-resistant prostate cancer (CRPC).
Gurveen Kaur
No relevant relationships to disclose
Beerinder Singh
No relevant relationships to disclose
Himisha Beltran
Research Funding - Janssen
Naveed Hassan Akhtar
No relevant relationships to disclose
David M. Nanus
Research Funding - Janssen
Scott T. Tagawa
Consultant or Advisory Role - Janssen
Honoraria - Janssen
Research Funding - Janssen